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Abstract
Immunoglobulin A vasculitis, formerly called Henoch-Schönlein purpura 
(HSP), is the most common systemic vasculitis in childhood. It is a small-vessel 
vasculitis mediated by type III hypersensitivity, manifested as rash accompanied 
by gastrointestinal (GI) symptoms, arthritis, and nephritis. The etiology of this 
disease (a leukocytoclastic vasculitis) is still uncertain, but immune complexes of 
IgA and unidentified antigens seem to have a central pathogenic role. Most often the 
diagnosis is established after the clinical examination; it is easy at first glance when 
the clinical presentation includes the classic tetrad of rash (nonthrombocytopenic 
palpable purpura), arthralgia/arthritis, abdominal pain, and renal manifestations 
but may be difficult when the gastrointestinal manifestations precede the skin 
purpuric rash. Gastrointestinal involvement is frequently seen and varies from 
mild symptoms to severe complications; sometimes the gastrointestinal symptoms 
(colicky abdominal pain, nausea, vomiting, diarrhea, gastrointestinal bleeding) 
are the first manifestations of the disease. Immunoglobulin A vasculitis is usually a 
self-limited disease with a benign course, and the treatment is often symptomatic; 
in severe cases corticosteroids are necessary.
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1. Introduction
In 1837 Schönlein described a clinical triad manifested as purpuric rash, arthral-
gias/arthritis, and renal involvement; 1 year later, Henoch related the association of 
rash, abdominal pain (with bloody diarrhea), and proteinuria; the clinical associa-
tion of these symptoms was diagnosed as Henoch-Schönlein purpura.
The term Henoch-Schönlein purpura was replaced with immunoglobulin A 
vasculitis (IgA vasculitis), by the 2012 revised Chapel Hill International Consensus 
Conference for Nomenclature of Vasculitides [1], based on IgA1-dominant immune 
deposits affecting small vessels and typically involving the skin, joints, gastrointes-
tinal tract, and kidney.
Henoch-Schönlein purpura (HSP) is a small-vessel vasculitis, characterized 
by a generalized vascular involvement, usually involving the small vessels of the 
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skin, the gastrointestinal (GI) tract, the kidneys, and the joints; it is an acute IgA-
mediated disorder that rarely may affect the lungs and the central nervous system 
(CNS) [2]. IgA vasculitis is a multi-system disorder characterized by palpable 
purpura, arthritis, glomerulonephritis, and gastrointestinal manifestations and is 
the most common form of systemic vasculitis for children (90% of cases occur in 
the pediatric patients) [3].
Although a lot of algorithm diagnoses were proposed (The American College 
of Rheumatology, Michel’s criteria, Chapel Hill Consensus Conference, etc.) 
[1], the diagnostic criteria remain the one published in 2006 [4], revised by the 
European League Against Rheumatism/Pediatric Rheumatology International 
Trial Organization/Pediatric Rheumatology European Society (EULAR/PRINTO/
PRES); the mandatory criterion is palpable purpura in association with at least one 
of the following: diffuse abdominal pain, arthritis or arthralgia, renal involvement 
(hematuria and/or proteinuria), and IgA deposition in biopsy specimen (skin, 
intestinal tract) [5].
Differential diagnosis includes many diseases with systemic manifestations 
(cutaneous, articular, gastrointestinal, renal) such as Crohn’s disease (no palpable 
purpura or gastrointestinal bleeding), IgA nephropathy (no palpable purpura), and 
hypersensitivity vasculitis (absence of IgA deposition) [4].
2. Epidemiology
IgA vasculitis is the most common vasculitis for children; it is usually seen in 
children between 3 and 10 years old (the age peak is 5–7 years) and very rarely in 
adults [3, 4]. The annual incidence varies greatly, from 13 to 20/100,000 for chil-
dren to 0.8–1.8/100,000 for adults [6–8]. Demographic data showed that males are 
more frequently affected (male-to-female ratio varies from 1.2:1 to 1.8:1) [3, 9].
The diagnosis is more commonly established in winter and spring and rarely in 
summer [7, 8], and this aspect may be explained by the association of this disease 
with infection factors, while approximately 50% of IgA cases are preceded by an 
upper respiratory tract infection [10].
Clinical features and severity of the disease also differ by aging, being more 
severe in adults than in children [10].
3. Pathogenesis
IgA vasculitis is a small-vessel vasculitis syndrome involving the small vessels of 
the skin, gastrointestinal tract, kidneys, and joints, consisting of palpable purpura, 
arthralgia, and gastrointestinal and renal manifestations.
The etiology is still unknown, but precipitating factors such as drug intake and/
or upper respiratory tract infections have been associated with the disease develop-
ment [11]. Although a variety of infectious and chemical triggers are recognized, 
the underlying cause remains unknown.
In approximately two-thirds of the cases, typical symptoms occur after 
7–14 days from an upper respiratory tract infection (previous epidemiological 
studies have found a seasonal variation of incidence in IgA vasculitis, with more 
cases occurring in autumn and winter related with upper respiratory tract infec-
tion) [4, 11].
Other cases of IgA vasculitis have been associated with several viral infections or 
vaccinations, foods, drugs, hematological malignancies, and tumors [4].
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Henoch-Schönlein purpura (HSP) is mediated by type III hypersensitivity with 
deposition of IgA immune complex in the walls of vessels.
Histologically, this disease is characterized by leukocytoclastic vasculitis accom-
panied by IgA immune complexes within affected organs (deposition of IgA and 
C3 in small-vessel walls, polymorphonuclear leukocyte infiltration around/in small 
blood vessels, and leukocytoclasia) [11]. The biopsy of the purpuric lesions showed 
the involvement of small vessels (primarily postcapillary venules) within the papil-
lary dermis and that the predominant cell types within the inflammatory infiltrate 
are neutrophils and monocytes [12].
Although the pathogenesis of the disease remains unknown, several authors 
confirmed the implication of abnormal glycosylation of the hinge region of IgA1, 
elevated levels of IgA anticardiolipin antibodies, and increased levels of transform-
ing growth factor (TGF)-beta in patients with Ig A vasculitis [12, 13].
The diagnosis is often a clinical one (based on the classic symptoms and signs); 
since there is no disease-specific laboratory abnormality, no specific test available 
was able to establish the diagnosis.
4. Clinical manifestation
IgA vasculitis typically has a prodrome (headache, anorexia, fever); after that, a 
lot of symptoms may develop: rash (especially involving the legs), abdominal pain 
and vomiting, joint pain (especially involving the knees and ankles), subcutaneous 
edema, scrotal edema, etc.
The classic tetrad symptoms are rash, arthralgia/arthritis, abdominal pain, 
and renal manifestations. The clinical diagnosis is easily made in the presence of 
all these symptoms but may be omitted when the clinical picture is incomplete; in 
the absence of the classic purpuric rash, the diagnosis of Ig A vasculitis may not be 
obvious [14, 15].
Purpura and joint pain are usually the main symptoms on admission, but the 
symptoms may develop over the course of some days to weeks and may vary in their 
order of presentation.
The major clinical manifestations are the following:
• Purpura—the appearing symptom in approximately 75% of patients, usually 
preceding other symptoms
• Arthralgia/arthritis—50–75% of cases
• Abdominal pain—colicky pain in 50% of cases and gastrointestinal bleeding in 
20–30% of cases
• Renal disease—20–50% [6, 11, 16–18]
4.1 Skin manifestation
The skin lesions are the earliest and most common appearance of the disease in 
the majority of patients (70%) and include palpable nonthrombocytopenic pur-
pura which evolves from erythema to papules and then to non-blanching palpable 
purpura with petechiae and ecchymosis (Figure 1). The rash is the hallmark of the 
disease and typically appears in crops, with new crops appearing in waves (erup-
tions usually last an average of 3 weeks).
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The typical rash is symmetrically distributed and located primarily in gravity-/
pressure-dependent areas, such as the feet, ankles, and lower legs in adults; in the 
case of children, the buttocks, face, trunk, and upper extremities are more affected 
[19]. In child patients purpura gradually disappears (it can recur and become 
chronic), but in adults, it may be necrotic or hemorrhagic in 1/3 of cases, and 
cutaneous exacerbations may be seen for 6 months or longer [20, 21].
4.2 Joint involvement
Arthralgia or arthritis is present in 2/3 of cases of patients; joint complaints are 
uncommon as the first symptom, but it is the appearing complaint in approximately 
25% of children [21]. The articular manifestations are seen more often in adults 
than in children; typically involve the hips, knees, and ankles (less commonly the 
upper extremities); and are symmetrical (as skin lesions) in distribution [4]. The 
joint involvement is usually transient or migratory, typically oligoarticular and non-
deforming. A prominent periarticular swelling and tenderness are usual, without 
joint effusion, erythema, or warmth. The most frequent symptom is arthralgia, 
while arthritis is very rare; joint effusions are exceptional [20].
4.3 Renal involvement
Renal involvement is found in 40–85% of patients (more prevalent in older 
children and adults), ranging from microscopic hematuria to progressive glomeru-
lonephritis, and is the most serious complication of Ig A vasculitis [17, 20]. The 
most common presentation is hematuria (with/without red blood casts) and mild 
proteinuria; proteinuria without hematuria is very rare. Renal manifestations usu-
ally develop within 4 weeks and never precede the onset of skin lesions. The risk of 
renal failure is rare in children [22] but may be present in about 30% of adult cases, 
especially in patients with nephrotic and nephritic syndromes [4]. Nephrotic-range 
proteinuria, elevated serum creatinine, hypertension, and the coexistence of hema-
turia and proteinuria are associated with an increased risk of renal failure; 2–5% of 
patients with renal involvement come to an end-stage renal failure [12, 17].
4.4 Gastrointestinal manifestations
Gastrointestinal involvement occurs in 50–75% of adult patients—abdominal 
pain and bloody diarrhea may precede the typical purpuric rash [15, 23]. The diges-
tive symptoms are often present in patients with IgA vasculitis, and although less 
commonly found in adults, they are more severe and often atypical. The gastroin-
testinal symptoms vary in intensity, and prudent laparotomy is required to exclude 
Figure 1. 
Palpable purpura on both ankles.
5Gastrointestinal Manifestations of IgA Vasculitis-Henoch-Schönlein Purpura
DOI: http://dx.doi.org/10.5772/intechopen.86966
an acute abdominal condition. Gastrointestinal manifestations range from mild 
(nausea, vomiting, abdominal pain, paralytic ileus) to severe findings (gastroin-
testinal bleeding, intussusception, bowel ischemia with secondary necrosis, bowel 
perforation).
Gastrointestinal symptoms are often the most debilitating manifestations of 
the disease, and they are much more common in younger patients than in elders 
[23, 24].
The gastrointestinal manifestations may precede the onset of IgA vasculitis or 
may develop later in the course of the disease. Typically, gastrointestinal symptoms 
develop within 8 days from the rash appearance, although longer periods (weeks, 
even months) have been described. In 10–15% of cases, the gastrointestinal symp-
toms occur before cutaneous manifestation, making the differential diagnosis of 
other causes of acute abdomen more difficult [24]. Rarely, gastrointestinal symp-
toms may appear with no cutaneous purpura at any time [25, 26].
Abdominal pain is the most common gastrointestinal symptom, manifested by 
colicky pain worsened by food (similar to bowel angina), localized to the epigastric 
and periumbilical regions. The pain is attributed to the involvement of the splanch-
nic circulation (mesenteric vasculitis) with bowel ischemia and edema of the 
gastrointestinal tract [4, 23, 27]. Abdominal pain associated with IgAV is caused by 
submucosal hemorrhage and edema.
Abdominal pain is often associated with diarrhea with gross or occult blood, 
nausea, vomiting, constipation, and gastrointestinal bleeding (hematemesis or 
melena).
In most cases, on clinical examination, the abdomen is tender and slightly dis-
tended; rarely, it may resemble and be confused with an acute abdomen requiring 
surgery evaluation (suspicion of perforation, intussusception). Some of these cases, 
suggesting an acute abdomen, are leading to emergency computed tomography 
(CT) or unnecessary surgery [4, 23]. Sometimes, particularly in young patients, 
intense abdominal pain may suggest acute appendicitis, especially when the skin 
rash is absent. Even in the presence of rash (suggestive in a clinical context for Ig A 
vasculitis) in front of intense abdominal pain, the differential diagnosis of abdomi-
nal pain and the exclusion of acute surgical abdomen are mandatory; more, the IgA 
vasculitis rash may be a nonspecific erythematous or urticarial exanthem or limited 
to lesions on the buttocks or lower extremities early in the disease course.
Gastrointestinal bleeding is another symptom, with an incidence varying between 
17.6 and 51% [23]. In most cases, the bleeding is occult (detected as positive 
stool occult blood); when manifested, the main symptom is melena rather than 
hematemesis or hematochezia, because the intestinal lesions are usually localized 
in the small bowel and colon. Gastrointestinal bleeding is usually mild; in rare cases 
it may be severe, requiring blood transfusion or surgical treatment, even leading to 
death [4, 23].
Other rare gastrointestinal manifestations, such as esophageal ulcer, pancreati-
tis, pseudomembranous colitis, gall bladder involvement, intestinal perforation, and 
ischemic vasculitis may occur [23].
Intussusception is the most common gastrointestinal complication of IgA 
vasculitis. Edema and hemorrhage can act as a pathological lead point, contributing 
to the development of intussusception. Intussusception is limited to the small bowel 
in approximately 60% of cases, in contrast to idiopathic intussusception, which is 
typically ileocolic. The overall incidence of this complication of IgA vasculitis varies 
between 2.3 and 3.5%, although some retrospective series reported an incidence of 
only 0.4 to 0.6% [9, 17]. Children with severe gastrointestinal pain and/or requiring 
hospitalization are at greater risk.
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4.4.1 Imaging evaluation of gastrointestinal manifestation
Upper gastrointestinal endoscopy (UGD) is mandatory in patients with gastroin-
testinal bleeding. UGD is helpful in the diagnosis of IgA vasculitis, especially when 
gastrointestinal symptoms develop prior to the cutaneous lesions.
The most important part of upper gastrointestinal tract is involved in the 
second part of the duodenum with endoscopic features including diffuse mucosal 
redness, petechiae, severe erosive duodenitis, hemorrhagic lesion, and ulcers 
[28] (Figure 2). Purpuric lesions may be seen on an endoscopy, commonly in the 
descending duodenum, stomach, and colon.
The spectrum of upper endoscopic findings is based upon the severity of the 
vasculitis; usually, irregular, ulcerating, nodular lesions or hematoma-like protru-
sions are characteristic of IgA vasculitis in the duodenum. The stomach and colon 
are often involved as well, but the duodenal bulb is rarely affected; the absence of 
bulbar lesions is important to exclude the cause of the peptic disease hemorrhage 
[29]. The biopsies of gastrointestinal lesions are commonly performed in patients 
with or without suspected IgA vasculitis in order to rule out infection, inflamma-
tory bowel disease, and less commonly, vasculitis. In general, vasculitis is not com-
monly observed in GI biopsies, and the spectrum of findings includes neutrophilic 
infiltrate within the small bowel and colon, with the duodenum most commonly 
affected. While the clinical and histologic findings may mimic early inflammatory 
bowel disease, the presence of predominant small bowel involvement, especially 
erosive duodenitis, should raise suspicion for IgA vasculitis. Biopsies should be 
obtained before steroid therapy is initiated, if possible [30].
Resolution of duodenal lesions is spectacular, in accordance with the remission 
of inflammatory disorders [31] (Figure 3).
Colonoscopy: erythema of the mucosa, petechiae, and ulcers are the most com-
mon findings [32].
Computed tomography (CT) imaging: the hallmarks of IgA vasculitis are multifo-
cal symmetric, circumferential, regular wall thickening and engorgement of mes-
enteric vessels. Associated findings include free intraperitoneal fluid, ileus of the 
affected loop, vascular engorgement in the adjoining mesentery, and nonspecific 
lymphadenopathy [24]. The target sign is not specific; it can be seen in many other 
conditions such as ischemic bowel disease, inflammatory bowel disease, infectious 
enterocolitis, radiation enteritis, etc. [19].
In some selected cases, CT angiography can be used to visualize the site of the 
arterial or venous occlusion; however, a normal angiogram does not rule out the 
possibility of mesenteric ischemia [3]. Mesenteric vascular engorgement and skip 
areas are also seen in Crohn’s disease, but terminal ileal involvement, stricture, 
fistula, and abscess would favor Crohn’s disease over other conditions [12, 33].
Figure 2. 
Endoscopic appearance of the second part of duodenum: multiple erosions, diffuse redness, submucosal 
hemorrhage, and small ulcerations.
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5. Conclusion
The diagnosis of IgA vasculitis (HSP) is usually based upon clinical manifesta-
tions of the disease, and in patients with an incomplete/unusual presentation, 
biopsy of the affected organ (e.g., skin or kidney) demonstrating predominantly 
IgA deposition supports the diagnosis. Although gastrointestinal involvement is 
frequent, the diagnosis of IgA vasculitis may be difficult when gastrointestinal 
manifestations occur alone or precede the characteristic skin purpura.
Figure 3. 
Endoscopic appearance of the second part of duodenum remission.
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